These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 26367070)
41. Tumor necrosis factor-alpha-308 gene polymorphism in Croatian and Slovenian multiple sclerosis patients. Ristić S; Lovrecić L; Starcević-Cizmarević N; Brajenović-Milić B; Sega Jazbec S; Sepcić J; Kapović M; Peterlin B Eur Neurol; 2007; 57(4):203-7. PubMed ID: 17268200 [TBL] [Abstract][Full Text] [Related]
42. Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms. Duszczyszyn DA; Beck JD; Antel J; Bar-Or A; Lapierre Y; Gadag V; Haegert DG Clin Exp Immunol; 2006 Feb; 143(2):305-13. PubMed ID: 16412055 [TBL] [Abstract][Full Text] [Related]
43. Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors. Thewissen K; Nuyts AH; Deckx N; Van Wijmeersch B; Nagels G; D'hooghe M; Willekens B; Cras P; Eijnde BO; Goossens H; Van Tendeloo VF; Stinissen P; Berneman ZN; Hellings N; Cools N Mult Scler; 2014 Apr; 20(5):548-57. PubMed ID: 24057429 [TBL] [Abstract][Full Text] [Related]
44. Variant of Chen S; Zhang J; Liu QB; Zhuang JC; Wu L; Xu YF; Li HF; Wu ZY; Xiao BG Chin Med J (Engl); 2018 Mar; 131(6):643-647. PubMed ID: 29521285 [TBL] [Abstract][Full Text] [Related]
45. Lack of association between the polymorphism at the heat-shock protein (HSP70-2) gene and systemic lupus erythematosus (SLE) in the Mexican mestizo population. Vargas-Alarcón G; Granados J; Martínez-Laso J; Gómez-Casado E; Zuñiga J; Salgado N; Hernández-Pacheco G; Hesiquio R; Rodríguez-Reyna TS; Gamboa R; Alcocer-Varela J; Arnaiz-Villena A Genes Immun; 2000 Aug; 1(6):367-70. PubMed ID: 11196683 [TBL] [Abstract][Full Text] [Related]
46. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194 [TBL] [Abstract][Full Text] [Related]
47. Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis. Al-Radaideh A; Mougin OE; Lim SY; Chou IJ; Constantinescu CS; Gowland P NMR Biomed; 2015 Nov; 28(11):1374-82. PubMed ID: 26346925 [TBL] [Abstract][Full Text] [Related]
52. HLA-DR,DQ and APOE genotypes and gender influence in Sardinian primary progressive MS. Cocco E; Sotgiu A; Costa G; Murru MR; Mancosu C; Murru R; Lai M; Contu P; Marrosu MG Neurology; 2005 Feb; 64(3):564-6. PubMed ID: 15699400 [TBL] [Abstract][Full Text] [Related]
53. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk. Strautins K; Tschochner M; James I; Choo L; Dunn DS; Pedrini M; Kermode A; Carroll W; Nolan D Mult Scler; 2014 Mar; 20(3):286-94. PubMed ID: 23886832 [TBL] [Abstract][Full Text] [Related]
54. Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate. Carrieri PB; Carbone F; Perna F; Bruzzese D; La Rocca C; Galgani M; Montella S; Petracca M; Florio C; Maniscalco GT; Spitaleri DL; Iuliano G; Tedeschi G; Della Corte M; Bonavita S; Matarese G Metabolism; 2015 Sep; 64(9):1112-21. PubMed ID: 25986733 [TBL] [Abstract][Full Text] [Related]
55. Analysis of genetic polymorphism of the HLA-B and HLA-DR loci in patients with dermatophytic onychomycosis and in their first-degree relatives. García-Romero MT; Granados J; Vega-Memije ME; Arenas R Actas Dermosifiliogr; 2012 Jan; 103(1):59-62. PubMed ID: 22456594 [TBL] [Abstract][Full Text] [Related]
56. Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis. Fainardi E; Bortolotti D; Bolzani S; Castellazzi M; Tamborino C; Roversi G; Baldi E; Caniatti ML; Casetta I; Gentili V; Granieri E; Rizzo R; Mult Scler; 2016 Feb; 22(2):245-9. PubMed ID: 26084349 [TBL] [Abstract][Full Text] [Related]
57. Cognitive impairment differs between primary progressive and relapsing-remitting MS. Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324 [TBL] [Abstract][Full Text] [Related]
58. Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population. Cocco E; Sardu C; Murru R; Frau J; Lorefice L; Mamusa E; Contu P; Marrosu MG Mult Scler; 2009 Sep; 15(9):1030-6. PubMed ID: 19625333 [TBL] [Abstract][Full Text] [Related]
59. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis. Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898 [TBL] [Abstract][Full Text] [Related]
60. Relapsing neuromyelitis optica and relapsing-remitting multiple sclerosis: differentiation at diffusion-tensor MR imaging of corpus callosum. Yu CS; Zhu CZ; Li KC; Xuan Y; Qin W; Sun H; Chan P Radiology; 2007 Jul; 244(1):249-56. PubMed ID: 17522347 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]